Elite Capital
Elite Capital is described in firmographic inputs as a Beijing-based venture capital and private equity firm targeting life sciences companies, founded 1998, with 51–100 employees. The only source-attributed data is a premium domain listing for sale.
- Company typePrivate
- Founded1998
- HeadquartersBeijing, China
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Elite Capital does
Per the firmographic inputs provided, Elite Capital is described as a venture capital and private equity firm based in Beijing, China, founded in 1998, with 51–100 employees, and a stated investment focus on life sciences companies. The firmographic record suggests a multi-decade operating history targeting the Chinese life-sciences sector, which would typically imply fund-management activity, limited-partner relationships, and portfolio company involvement across biopharma, medtech, or healthcare services. A single named individual, Matthew Estes, is listed as Managing Director.
However, the only source-attributed evidence materially contradicts this picture. That source consists exclusively of a Spaceship.com for-sale listing page for the domain elite-capital.com, priced at $19,888 buy-now or best offer, with no incorporation data, no operating history, no leadership bios, no fund disclosures, and no portfolio information. The source explicitly states that "no substantive information about an actual company entity, its operations, founding, or business activities is present in the source data." This leaves the gap between the firmographic narrative and the verifiable record wide open.
The discrepancy between the firmographic description (an established Beijing-based VC/PE firm) and the sole source-attributed artifact (a parked premium domain listed for sale) is the central analytical caveat. No products, services, technology stack, revenue, funding rounds, M&A activity, customer relationships, geographic markets served, regulatory standing, or partnership history are supported by any source-attributed data. Investment conclusions drawn solely from the firmographic block should be treated as unverified.
Elite Capital firmographics
Firmographics- Name
- Elite Capital
- Website
- https://elite-capital.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Elite Capital is described in firmographic inputs as a Beijing-based venture capital and private equity firm targeting life sciences companies, founded 1998, with 51–100 employees. The only source-attributed data is a premium domain listing for sale.
- Ownership category
- akta.pro rank
Elite Capital industry classification
Industry- Product category
- Venture Capital and Private Equity
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
- akta.pro secondary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where Elite Capital is headquartered
LocationHeadquarters
- HQ city
- Beijing
- HQ country
- China
- HQ region
- Asia
Markets served
Elite Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Domain sale price |
Distribution channels1 record
Marketing channels1 record
Elite Capital product offering
Product offeringCore offering
Elite Capital is identified in firmographic data as a venture capital and private equity firm that invests in life sciences companies, providing equity capital and investment management services to growth-stage and established businesses in the sector. The firm was founded in 1998 and is headquartered in Beijing, China, with 51-100 employees. The firm's web property, elite-capital.com, is currently a domain listed for sale on the Spaceship.com marketplace at $19,888.
Differentiator
Problem solved
Functional benefit
Products and services
- elite-capital.com domain Premium two-word .com domain name combining 'Elite' (signifying premium quality) and 'Capital' (indicating financial services), listed for sale on the Spaceship.com marketplace at a buy-now price of $19,888. Suitable for financial services, capital management, or investment firm branding, offering a memorable and professional web address with the most trusted TLD extension. Buyers can also submit offers, and the listing supports multiple payment methods including credit cards, PayPal, ApplePay, GooglePay, AliPay, Bitcoin, and Wire Transfer.
Companies that use Elite Capital
Customer profileSegments1 record
Ideal customer profiles1 record
Elite Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Elite Capital partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
Elite Capital competitors and assessment
Company assessmentDirect peers
- Qiming Venture Partners: China-focused venture and growth equity firm with a dedicated healthcare/life sciences practice that invests across therapeutics, medical devices, and diagnostics, making it the closest direct comparable to a China-based life sciences growth equity specialist.
- Hillhouse Capital: Asia-focused investment manager with significant healthcare exposure across venture, growth, and buyout stages; operates at comparable institutional scale from a Beijing/Asia base and targets many of the same life sciences opportunities.
- FountainVest Partners: China-headquartered private equity firm that invests across consumer, healthcare, and technology, with healthcare being a core vertical; comparable in mandate and geography to an Asia life sciences growth investor.
- OrbiMed: Global healthcare-dedicated investment firm covering venture, growth, and buyout stages in life sciences; directly comparable as a specialist in the same vertical, though with a more global (less China-centric) footprint.
- Vivo Capital: Healthcare-focused investment firm with deep activity across China and Asia across venture, growth, and public-equity stages in life sciences; highly comparable as a vertical specialist in the same region.
Broad incumbents
- CDH Investments: One of the largest China-focused private equity managers with broad sector exposure including healthcare; overlaps with Elite Capital in life sciences but operates at much larger scale and across multiple verticals.
- Boyu Capital: Asia-rooted private equity firm with significant healthcare/life sciences deal activity in Greater China; comparable as a generalist PE with a major healthcare vertical presence in the same geography.
- Sequoia Capital China: Major China venture and growth equity platform investing across technology and healthcare/life sciences; comparable because of overlapping deal universe in Chinese biotech, despite its broader sector mandate.
- Warburg Pincus: Global growth investor with a substantial healthcare practice active in China, including therapeutics and medical technology; overlaps with Elite Capital's life sciences focus though Warburg is a broad-based generalist.
- Bain Capital Asia: Asia-Pacific private equity platform with dedicated healthcare investing in China and the region; comparable as a larger, generalist PE with material overlap in the life sciences deal universe.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
Elite Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Elite Capital leadership team
Management profileNumber of profiles
Profiles1 record
Elite Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Elite Capital M&A and investment
M&A and investmentM&A
Investments6 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Elite Capital
What does Elite Capital do?
Elite Capital is identified in firmographic data as a venture capital and private equity firm that invests in life sciences companies, providing equity capital and investment management services to growth-stage and established businesses in the sector. The firm was founded in 1998 and is headquartered in Beijing, China, with 51-100 employees. The firm's web property, elite-capital.com, is currently a domain listed for sale on the Spaceship.com marketplace at $19,888.
When was Elite Capital founded?
Elite Capital was founded in 1998. It employs 51 to 100 people.
Where is Elite Capital based?
Elite Capital is headquartered in Beijing, China, in the Asia region.
Who are Elite Capital's main competitors?
Direct peers on record are Qiming Venture Partners, Hillhouse Capital, FountainVest Partners, OrbiMed and Vivo Capital. Broad incumbents are CDH Investments, Boyu Capital, Sequoia Capital China, Warburg Pincus and Bain Capital Asia.
Does Elite Capital have an API?
No public API is recorded for Elite Capital.
What industry is Elite Capital in?
Elite Capital's product category is Venture Capital and Private Equity. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 523940 and its SIC code is 6282.